Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19 (EndoCom)

December 28, 2020 updated by: Thomas Seufferlein, University of Ulm

Impact of Digital Enhanced Telecommunication for Team Communication in Endoscopic Procedures During COVID-19 Pandemic

Team work is highly challenged by the COVID-19 pandemic. Necessary protective equipment as FFP-mask and face shields impair communication significantly.Objective of the study is to evalaute the impact of digital enhanced telecommunication in endoscopic procedures.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Optimal communication is crucial for team work in high class endoscopy. Team work is highly challenged by the COVID-19 pandemic. Necessary protective equipment as FFP-mask and face shields impair communication significantly. Digital enhanced approaches to maintain team communication during endoscopic procedures are mandatory not only in actual circumstances.

Materials and methods:A prospective, two-armed interventional study will be performed at an endoscopy unit at a tertiary center. 200 endoscopic examinations (EGD, colonoscopy, EUS, ERCP) were randomly assigned (1:1) to a group that was performed with DECT equipped endoscopy team or with standard communication. All examinations were performed under protective equipment. Primary outcome was rate of communication associated adverse events. Secondary outcomes included team subjectively perceived comfort with DECT enhanced communication during endoscopic work, duration of examinations, SAE.

Study Type

Interventional

Enrollment (Anticipated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ulm, Germany
        • Universitätsklinikum Ulm

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Member of staff of the endoscopic team (Doctor, nurse)

Exclusion Criteria:

  • Deafness
  • significantly impaired hearing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard Communication
Endoscopic procedures performed by skilled endoscopic team with standard communication (no headset)
Experimental: DECT enhanced Communication
Endoscopic procedures performed by skilled endoscopic team with enhanced communication tools ( DECT headset)
Use of a digital enhanced telecommunication headset for team communication

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Communication associated adverse events
Time Frame: From start to stop of endoscopic procedure
Adverse events arising from impaired communication by COVID-19 protection equipment
From start to stop of endoscopic procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severe adverse events
Time Frame: From start to stop of endoscopic procedure
Severe adverse evatent, not arising from from impaired communication by COVID-19 protection equipment
From start to stop of endoscopic procedure
Subjective Comfort of DECT communication
Time Frame: From start to stop of endoscopic procedure
Subjectiveley perceived level of comfort using DECT communication during endoscopic procedures rated by numeric rating scale (1-6)
From start to stop of endoscopic procedure
Endoscopic time
Time Frame: From start to stop of endoscopic procedure
Duration of performed endoscopic procedures
From start to stop of endoscopic procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Anticipated)

January 31, 2021

Study Completion (Anticipated)

February 15, 2021

Study Registration Dates

First Submitted

December 17, 2020

First Submitted That Met QC Criteria

December 17, 2020

First Posted (Actual)

December 23, 2020

Study Record Updates

Last Update Posted (Actual)

December 31, 2020

Last Update Submitted That Met QC Criteria

December 28, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication

Clinical Trials on DECT

Subscribe